Published: Guidance, quality standards and advice
Showing 31 to 40 of 2549
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer | TA1138 | ||
| Rare diseases | QS214 | ||
| Blood transfusion | QS138 | ||
| Molnupiravir for treating COVID-19 | TA1056 | ||
| Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19 | TA878 | ||
| Hypertension in adults: diagnosis and management | NG136 | ||
| Blood transfusion | NG24 | ||
| Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy for metastatic colorectal cancer | TA1136 | ||
| Canagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) | TA1137 | ||
| Leadless cardiac pacemaker implantation for bradyarrhythmias | HTG770 |